Hepatic microRNA expression is associated with the response to interferon treatment of chronic hepatitis C

BMC Medical Genomics

Volumn 3, Issue , 2010, Pages

  Murakami, Yoshiki ^a   Tanaka, Masami ^b   Toyoda, Hidenori ^c   Hayashi, Katsuyuki ^d   Kuroda, Masahiko ^b   Tajima, Atsushi ^e   Shimotohno, Kunitada ^f  

^a KYOTO UNIVERSITY   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

^c OGAKI MUNICIPAL HOSPITAL   (Japan)

^d DNA CHIP RESEARCH INC   (Japan)

^e TOKAI UNIVERSITY   (Japan)

^f CHIBA INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; PEGINTERFERON ALPHA2B; RIBAVIRIN; INTERFERON;

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; EMBRYO; FEMALE; GENE EXPRESSION PROFILING; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MONTE CARLO METHOD; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE; CELL STRAIN HEK293; DRUG COMBINATION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LIVER; METABOLISM; MIDDLE AGED; POLYMERASE CHAIN REACTION; REPRODUCIBILITY; TIME; TREATMENT OUTCOME;

HEPATITIS C VIRUS;

DRUG COMBINATIONS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEK293 CELLS; HEPATITIS C, CHRONIC; HUMANS; INTERFERONS; LIVER; MALE; MICRORNAS; MIDDLE AGED; MONTE CARLO METHOD; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77958064862     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-3-48     Document Type: Article

References (33)

1. Immunobiology and pathogenesis of viral hepatitis. LG Guidotti FV Chisari, Annu Rev Pathol 2006 1 23 61 10.1146/annurev.pathol.1.110304.100230 18039107
2. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. MW Fried ML Shiffman KR Reddy C Smith G Marinos FL Goncales D Haussinger M Diago G Carosi D Dhumeaux A Craxi A Lin J Hoffman J Yu, N Engl J Med 2002 347 13 975 982 10.1056/NEJMoa020047 12324553
3. The functions of animal microRNAs. V Ambros, Nature 2004 431 7006 350 355 10.1038/nature02871 15372042
4. Mechanisms of microRNA-mediated gene regulation in animal cells. TW Nilsen, Trends Genet 2007 23 5 243 249 10.1016/j.tig.2007.02.011 17368621
5. Ribo-gnome: the big world of small RNAs. PD Zamore B Haley, Science (New York, NY) 2005 309 5740 1519 1524
6. MicroRNA function: multiple mechanisms for a tiny RNA? RS Pillai, RNA (New York, NY) 2005 11 12 1753 1761
7. Identification of tissue-specific microRNAs from mouse. M Lagos-Quintana R Rauhut A Yalcin J Meyer W Lendeckel T Tuschl, Curr Biol 2002 12 9 735 739 10.1016/S0960-9822(02)00809-6 12007417
8. Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy. M Sarasin-Filipowicz J Krol I Markiewicz MH Heim W Filipowicz, Nat Med 2009 15 1 31 33 10.1038/nm.1902 19122656
9. MicroRNA expression, survival, and response to interferon in liver cancer. J Ji J Shi A Budhu Z Yu M Forgues S Roessler S Ambs Y Chen PS Meltzer CM Croce LX Qin K Man CM Lo J Lee IO Ng J Fan ZY Tang HC Sun XW Wang, N Engl J Med 2009 361 15 1437 1447 10.1056/NEJMoa0901282 19812400
10. Interferon modulation of cellular microRNAs as an antiviral mechanism. IM Pedersen G Cheng S Wieland S Volinia CM Croce FV Chisari M David, Nature 2007 449 7164 919 922 10.1038/nature06205 17943132 (Pubitemid 47598616)
11. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. CL Jopling M Yi AM Lancaster SM Lemon P Sarnow, Science (New York, NY) 2005 309 5740 1577 1581
12. Regulation of the hepatitis C virus genome replication by miR-199a(*). Y Murakami HH Aly A Tajima I Inoue K Shimotohno, J Hepatol 2009 50 3 453 460 10.1016/j.jhep.2008.06.010 19144437
13. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Enomoto I Sakuma Y Asahina M Kurosaki T Murakami C Yamamoto Y Ogura N Izumi F Marumo C Sato, N Engl J Med 1996 334 2 77 81 10.1056/NEJM199601113340203 8531962
14. Prediction of response to pegylated interferon and ribavirin in hepatitis C by polymorphisms in the viral core protein and very early dynamics of viremia. N Akuta F Suzuki Y Kawamura H Yatsuji H Sezaki Y Suzuki T Hosaka M Kobayashi M Kobayashi Y Arase K Ikeda Y Miyakawa H Kumada, Intervirology 2007 50 5 361 368 10.1159/000107707 17728547
15. Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C. T Asselah I Bieche S Narguet A Sabbagh I Laurendeau MP Ripault N Boyer M Martinot-Peignoux D Valla M Vidaud P Marcellin, Gut 2008 57 4 516 524 10.1136/gut.2007.128611 17895355
16. Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response. JJ Feld S Nanda Y Huang W Chen M Cam SN Pusek LM Schweigler D Theodore SL Zacks TJ Liang MW Fried, Hepatology 2007 46 5 1548 1563 10.1002/hep.21853 17929300
17. Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection. L Chen I Borozan J Feld J Sun LL Tannis C Coltescu J Heathcote AM Edwards ID McGilvray, Gastroenterology 2005 128 5 1437 1444 10.1053/j.gastro.2005.01.059 15887125
18. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Y Tanaka N Nishida M Sugiyama M Kurosaki K Matsuura N Sakamoto M Nakagawa M Korenaga K Hino S Hige Y Ito E Mita E Tanaka S Mochida Y Murawaki M Honda A Sakai Y Hiasa S Nishiguchi A Koike I Sakaida M Imamura K Ito K Yano N Masaki F Sugauchi N Izumi K Tokunaga M Mizokami, Nature genetics 2009 41 10 1105 1109 10.1038/ng.449 19749757
19. Early gene expression profiles of patients with chronic hepatitis C treated with pegylated interferon-alfa and ribavirin. ZM Younossi A Baranova A Afendy R Collantes M Stepanova G Manyam A Bakshi CL Sigua JP Chan AA Iverson CD Santini SY Chang, Hepatology 2009 49 3 763 774 10.1002/hep.22729 19140155
20. A prediction-based resampling method for estimating the number of clusters in a dataset. S Dudoit J Fridlyand, Genome Biol 2002 3 7 ESEARCH0036 10.1186/gb-2002-3-7-research0036 12184810
21. Bagging to improve the accuracy of a clustering procedure. S Dudoit J Fridlyand, Bioinformatics 2003 19 9 1090 1099 10.1093/bioinformatics/btg038 12801869
22. National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002 - June 10-12, 2002. Hepatology 2002 36 5 Suppl 1 3 20 12407572
23. Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin. P Ferenci MW Fried ML Shiffman CI Smith G Marinos FL Goncales D Haussinger M Diago G Carosi D Dhumeaux A Crax M Chaneac KR Reddy, J Hepatol 2005 43 3 425 433 10.1016/j.jhep.2005.04.009 15990196
24. MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation. E Sonkoly M Stahle A Pivarcsi, Seminars in cancer biology 2008 18 2 131 140 10.1016/j.semcancer.2008.01.005 18291670
25. microRNAs and the immune response. MA Lindsay, Trends in immunology 2008 29 7 343 351 10.1016/j.it.2008.04.004 18515182
26. The developmental miRNA profiles of zebrafish as determined by small RNA cloning. PY Chen H Manninga K Slanchev M Chien JJ Russo J Ju R Sheridan B John DS Marks D Gaidatzis C Sander M Zavolan T Tuschl, Genes & development 2005 19 11 1288 1293
27. Computational identification of hepatitis C virus associated microRNA-mRNA regulatory modules in human livers. X Peng Y Li KA Walters ER Rosenzweig SL Lederer LD Aicher S Proll MG Katze, BMC Genomics 2009 10 373 10.1186/1471-2164-10-373 19671175
28. MicroRNA-513 regulates B7-H1 translation and is involved in IFN-gamma-induced B7-H1 expression in cholangiocytes. AY Gong R Zhou G Hu X Li PL Splinter SP O'Hara NF LaRusso GA Soukup H Dong XM Chen, J Immunol 2009 182 3 1325 1333 19155478
29. The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. D Yu S Rao LM Tsai SK Lee Y He EL Sutcliffe M Srivastava M Linterman L Zheng N Simpson JI Ellyard IA Parish CS Ma QJ Li CR Parish CR Mackay CG Vinuesa, Immunity 2009 31 3 457 468 10.1016/j.immuni.2009.07.002 19631565
30. ViTa: prediction of host microRNAs targets on viruses. PW Hsu LZ Lin SD Hsu JB Hsu HD Huang, Nucleic acids research 2007 35 Database issue 381 385 10.1093/nar/gkl1009 17148483
31. Division of labor, plasticity, and crosstalk between dendritic cell subsets. B Pulendran H Tang TL Denning, Curr Opin Immunol 2008 20 1 61 67 10.1016/j.coi.2007.10.009 18082389
32. Direct enumeration and functional assessment of circulating dendritic cells in patients with liver disease. AM Wertheimer A Bakke HR Rosen, Hepatology 2004 40 2 335 345 10.1002/hep.20306 15368438
33. American Gastroenterological Association technical review on the management of hepatitis C. JL Dienstag JG McHutchison, Gastroenterology 2006 130 1 231 264 10.1053/j.gastro.2005.11.010 16401486